Arix Bioscience PLC
LSE:ARIX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| UK |
|
Arix Bioscience PLC
LSE:ARIX
|
183.8m GBP |
Loading...
|
|
| US |
|
Blackstone Inc
NYSE:BX
|
181.4B USD |
Loading...
|
|
| US |
|
BlackRock Inc
NYSE:BLK
|
170.9B USD |
Loading...
|
|
| CA |
|
Brookfield Corp
NYSE:BN
|
106.4B USD |
Loading...
|
|
| US |
|
KKR & Co Inc
NYSE:KKR
|
103.5B USD |
Loading...
|
|
| CA |
B
|
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
|
112.8B CAD |
Loading...
|
|
| US |
|
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
|
68.9B EUR |
Loading...
|
|
| CA |
|
Brookfield Asset Management Inc
NYSE:BAM
|
82.9B USD |
Loading...
|
|
| US |
|
Bank of New York Mellon Corp
NYSE:BK
|
81.6B USD |
Loading...
|
|
| SE |
|
EQT AB
STO:EQT
|
415.8B SEK |
Loading...
|
|
| US |
|
Ameriprise Financial Inc
NYSE:AMP
|
46.4B USD |
Loading...
|
Market Distribution
| Min | -195 650% |
| 30th Percentile | 0% |
| Median | 0.1% |
| 70th Percentile | 0.2% |
| Max | 4 630.7% |
Other Profitability Ratios
Arix Bioscience PLC
Glance View
Arix Bioscience Plc is a global venture capital company. The firm is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. The firm's principal activity is to source, finance and develop healthcare and life science businesses across the world. The firm focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company’s portfolio includes Harpoon Therapeutics, Inc. (HARP), Artios Pharma Ltd (Artios), Aura Biosciences Inc (Aura), LogicBio Therapeutics, Inc. (LOGC). The firm's subsidiaries include Depixus SAS (EUR), Quench Bio, Inc., Stipe Therapeutics Aps and Twelve Bio Aps.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Arix Bioscience PLC is -7 826%, which is below its 3-year median of -6 275.9%.
Over the last 2 years, Arix Bioscience PLC’s Operating Margin has decreased from -1 273.5% to -7 826%. During this period, it reached a low of -7 826% on Jul 30, 2023 and a high of -1 273.5% on May 30, 2021.